Popis obrázku
Encyclopaedia
encyklopedie-bg.svg
encyklopedie.svg

Please note that the information provided below is the personal opinion of Mr Milan Schirlo, who is a therapist and an advocate of Traditional Chinese Medicine and a healthy lifestyle. Mr Schirlo does not promote any specific products or manufacturers of food supplements. Furthermore, this article is not connected to the sale of any products. The information is provided for the purpose of disseminating publicly available knowledge, conclusions of professional studies, education, and personal findings regarding vital mushrooms and a healthy lifestyle.

For legislative reasons, I cannot state some information. Therefore, the text is missing for some points. I am working on republishing it. Thank you for your understanding.

Agarikon

Latin: Laricifomes officinalis

Czech: Larch Polypore

About Agarikon

Larch Polypore (Laricifomes officinalis, Polyporus officinalis, Fomitopsis officinalis, Agarikon, Quinine conk) belongs to the polypore wood-decaying mushrooms. It appears mainly in the northern hemisphere, i.e., it prefers cooler temperatures. It has therefore been found in Europe, e.g., in the Alps, the Carpathians, and it also occurs in Canada, Russia, and the cooler regions of Asia.

Agarikon prefers coniferous trees, namely larches. A perennial, multi-year fruiting body forms on the bark of the trees (it is stated that the oldest fruiting bodies were up to 75 years old), which resembles a column or a hoof. The fruiting body can be 60 centimetres or more in length.

Young, developing fruiting bodies are soft and light beige, yellowish, whitish. Gradually, however, they darken and also harden.

Although the mushroom is edible, it is not consumed. This is partly due to its structure and also its taste, which is distinctly bitter and unpleasant. Although Agarikon has not found use in the kitchen, its popularity is enormous. It has been used for centuries as a medicinal remedy. It has "always" been dried and crushed into a powder or into larger pieces, which are used to make teas or decoctions. In ancient writings from the year 65 AD written by Pedanius Dioscorides, Agarikon is described as a medicine that helps patients with tuberculosis or chickenpox; it was also used against excessive sweating and as a laxative. Agarikon is very popular in Iran, where it is an integral part of their traditional medicine. Here it is called Gharikon and is used in the treatment of sciatica, muscle weakness, bronchitis and lung inflammation, constipation, stomach pain, and poor digestion; it reduces fever and alleviates the consequences of insect bites. It is also used as a diuretic, i.e., it supports the production and excretion of urine.

Agarikon was also used by the indigenous peoples of North America, both as a medicine and as a tool in shamanic rituals. The indigenous people even carved figurines from it. They used Agarikon as a remedy that has an astringent effect on blood vessels and thus accelerates the stopping of bleeding. It was also valued as a medicine for lung diseases and used for joint and muscle pain in the form of compresses.

Effects verified by practice in more detail:

1, Stimulation of the immune system and protection against infection

  • Agarikon stimulates the immune system, thereby protecting against infection
  • it is most often combined with Coriolus, Reishi, and Shiitake mushrooms

2, Support for cancer treatment

  • Agarikon is used in cancer prevention in high-risk groups
  • it is suitable as a complementary cancer therapy

3, Anti-inflammatory effects

  • Agarikon is used for chronic inflammation
  • a typical use of this effect is rheumatoid arthritis

4, Digestive support

  • it is used for digestive problems
  • it supports intestinal peristalsis

5, Asthma

  • it is used for shortness of breath and asthmatic difficulties

6, Detoxification

  • Agarikon can detoxify the organism and remove various toxic substances from it

Dosage:

  • mushrooms can be taken in various forms. The form of hot-water extracts with 30% polysaccharides is most often used for health problems.
  • as with other mushrooms, I recommend taking them for 5 days and taking a 2-day break, especially if solving problems related to the immune system (even secondarily, i.e., I use this rule almost always)
  • you can learn more about using vital mushrooms here

a, Mushrooms in the form of extracts (recommended form of use)

If you are taking mushrooms in the form of 30% extracts, I recommend:

Preventive use

  • 1 g of mushroom extract per day (all mushrooms combined)

For milder health problems

  • 2 g of mushroom extract per day (all mushrooms combined)

For more serious health problems

  • 3-5 g of mushroom extract per day (all mushrooms combined)

b, Mushrooms in tincture

  • dose the tincture according to weight
  • usually, as many drops are given as a person weighs
  • this daily dose is divided in half, half is taken in the morning and half at noon

c, Mushrooms in the form of powder (powder, biomass)

  • usually 2-3 times a day a teaspoon of mushroom powder mixed in water
  • this is more of a preventive use

d, Dried mushrooms

  • 20-100 g per day
  • they are either added to food or decoctions are made from them
  • you prepare a decoction by taking 100 g of mushrooms and putting them into about half a litre of cold water and boiling for half an hour on a low flame. Some mushrooms can be eaten with the decoction (e.g., Hericium), some are too woody to eat (like Reishi).

Contraindications and known drug interactions:

Pharmacological effect:

  • Antimicrobial effects
  • Immunostimulatory and anti-inflammatory effects
  • Antitumour effects
  • Antitumour effects

Active substances in Agarikon:

Composition of Agarikon, substances in milligrams per 100 grams of dry matter. The abbreviation nd means that no traces of this compound were found.

Substance name

fruiting body (mg/100 g dry matter)

mycelium (mg/100 g dry matter)

Indole components

l-tryptophan

70.08 ± 6.16a

8.06 ± 0.96a

6-Methyl-d,l-tryptophan

9.24 ± 1.34a,b

0.53 ± 0.06a,b

Melatonin

1.51 ± 0.52a,b

0.34 ± 0.03a,c

5-Hydroxy-l-tryptophan

*

517.99 ± 5.29a,b,c

Phenolic components

p-Hydroxybenzoic acid

0.07 ± 0.00

*

Catechin

nd

58.37 ± 0.9

Gallic acid

nd

0.09 ± 0.0

Amino acids

Phenylalanine

nd

346.48 ± 4.0

Sterols

Ergosterol

52.97 ± 0.21

102.02 ± 0.44

Ergosterol peroxide

*

*

Bioelements

Zinc

9.62 ± 0.42

15.34 ± 0.55

Copper

3.22 ± 0.31

0.72 ± 0.04

Iron

4.15 ± 0.12

12.06 ± 1.37

Magnesium

189.5 ± 2.69

218.9 ± 12.13

Secondary metabolites

Component

antimicrobial/antiparasitic effects

eburicoic acid

sulfurenic acid

Fomefficinic acid A-E

Versisponic acid D

Fomefficinic acid F,G

Dehydroeburicoic acid

Dehydrosulfurenic acid

3-Ketodehydrosulfurenic acid

Fomefficinol A-B

Fomlactone A-C

Obtusifoldienol

Eburicodiol

(3β,5α,6β)-3,6-dihydroxy-4,4,14-trimethyl-Pregn-8- en-20-one

3α-hydroxy-4,4,14α-trimethyl-5α-pregn-8-en-20-one

Eburical

Agaric acid

Laricinoic acid

Officinalic acid

2H-6-chloro-2-oxo-4-phenyl-1-Benzopyran-3-carboxylicacidethylester

antimicrobial

6-Chloro-4-phenyl-coumarin

antimicrobial

Officimalonic acid A-H

Fomitopsin A

Fomitopsin C

Fomitopsin F, G, H

Trypanocidal

Demalonyl fomitopsin H

Trypanocidal

Fomitopsin D Ethyl ester

Trypanocidal

3-acetyloxylanosta-8, 24-dien-21-oic acid

(25S)-(+)-12α-hydroxy-3α-malonyloxy-24-methyllanosta-8,24(31)-dien-26-oic acid

15α-hydroxy-3-oxo-24-methylenelanosta-7,9(11)-dien-21-oic acid

Trypanocidal

t-Z-trans-zeatin

c-Z-cis-zeatin

ZR-zeatin riboside

zeatin-glucoside

Girometta C. Antimicrobial properties of Fomitopsis officinalis in the light of its bioactive metabolites: a review. Mycology. 2018;10(1):32-39. Published 2018 Oct 25. doi:10.1080/21501203.2018.1536680

Important polysaccharides are also missing from the list. In Agarikon, these are mainly mannofucogalactans, which are composed of many monosaccharides. They contain mainly galactose, fucose, and mannose. There are also "classic" beta-glucans in Agarikon.

Effects of Agarikon

Agarikon is both a part of many traditional medicines and many of its effects are confirmed in studies. We will mention some of them.

Waill A Elkhateeb, Ghoson M Daba, Marwa O Elnahas, Paul W Thomas. Fomitopsis officinalis mushroom: ancient gold mine of functional components and biological activities for modern medicine. Egyptian Pharmaceutical Journal 18(4):285-289

Antimicrobial effects:

Microbes that can cause infectious diseases are all around us. It mainly depends on the immune system whether it can repel their onslaught. The fact that we do not get sick does not mean that we have not caught a microbe. It is just immediately liquidated.

Agarikon has significant antimicrobial effects.

It can make life unpleasant for viruses. It can limit their entry into the cell, limit the activity of their enzymes, thereby limiting their replication, i.e., multiplication. Agarikon has been tested against the smallpox virus, hepatitis C, herpes viruses, and influenza viruses. It can even destroy the bird flu virus.

Antibacterial effects have also been proven. If Agarikon is added to bacteria, they stop multiplying and die. This also applies to Mycobacterium tuberculosis, which causes tuberculosis. This bacterium is extremely resistant; to eliminate it, it is necessary to use up to 4 antibiotics at once. Agarikon further destroys Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae (pneumococcus), Enterococcus faecalis, Pseudomonas aeruginosa, Klebsiella pneumoniae, Listeria monocytogenes, Salmonella typhimurium, etc.

Agarikon also acts against fungi and yeasts, e.g., against Candida albicans and Alternaria solani, Fusarium oxysporum, and Aspergillus terreus.

Agarikon also has antiparasitic effects. These have been proven against Trypanosoma congolense. This is a parasite related to the trypanosome that causes sleeping sickness in humans.

Influence on the immune system:

Agarikon contains components that influence the functioning of the immune system, which is essential for our health.

Agarikon can strengthen the immune response. Polysaccharides are mainly responsible for this. Under the influence of Agarikon, the activity of immune cells increases, they produce more cytokines, the ability of macrophages to engulf foreign material or damaged parts of cells is strengthened, they kill engulfed microbes better, etc.

Agarikon does not only have immunity-strengthening effects, but it can also suppress undesirable inflammation. Although inflammation is a healing process, if it is disproportionate and long-term, it can lead to tissue damage. We see this also in autoimmune and allergic inflammation. Triterpene lanostanes, which include officinomalonic acids and fomitopsin A, have suppressive effects.

Antitumour effects:

Tumour diseases are still increasing. Despite new treatment procedures, there are patients who succumb to the disease, and the treatment itself is very demanding. Scientists are therefore looking for substances that have antitumour effects but do not damage the healthy cells of the body.

The effects of Agarikon have been tested on breast, liver, lung, osteosarcoma, and cervical cancer. If Agarikon was added to these cells, they stopped multiplying and began to die. Lanostane triterpenes such as fomitopsin C are mainly behind this effect.

Experiments have also been carried out on animals with tumour diseases. Part of the animals is treated with Agarikon and part is not. It is compared how the tumour behaved during the study. In mice that received Agarikon, the tumour shrank, and necrosis, i.e., death, was evident in it. Doses of 20 mg/l can reduce tumour growth by more than 65%.

Besides the direct effect on tumour cells, Agarikon also limits the formation of new blood vessels, which tumour cells stimulate. Tumour cells require a greater supply of energy, and this ensures sufficient blood supply. Limiting the formation of new blood vessels that supply the tumour with blood also limits the growth of the tumour.

We cannot omit the fact that Agarikon increases the activity of the immune system, and therefore also antitumour immunity.

Other effects:

Thanks to its components, Agarikon has antioxidant effects, i.e., it limits oxidative stress, thereby slowing down degenerative processes and reducing the risk of tumour diseases.

It has also been proven that it suppresses the activity of thrombin, thus reducing the formation of thrombi, i.e., blood clotting.

Blanchette RA, Compton BD, Turner NJ, Gilbertson RL. 1992. Nineteenth century shaman grave guardians are carved Fomitopsis officinalis sporophores. Mycologia. 84(1):119–124.
Masahiko Isaka, et al. Fomitopsins I and J, 24-methyl-lanostane triterpenoids from fruiting bodies of the wood-rot basidiomycete Fomitopsis sp. Phytochemistry Letters, Volume 29, February 2019, Pages 178-181
Vazirian M, Faridfar S, Eftekhari M. "Gharikon"/"Agharikon" a Valuable Medicinal Mushroom in Iranian Traditional Medicine. Iran J Med Sci. 2016;41(3 Suppl):S34.
Hwang CH, Jaki BU, Klein LL, et al. Chlorinated coumarins from the polypore mushroom Fomitopsis officinalis and their activity against Mycobacterium tuberculosis. J Nat Prod. 2013;76(10):1916–1922. doi:10.1021/np400497f
Girometta C. Antimicrobial properties of Fomitopsis officinalis in the light of its bioactive metabolites: a review. Mycology. 2018;10(1):32–39. Published 2018 Oct 25. doi:10.1080/21501203.2018.1536680
International Journal of Medicinal Mushrooms > Volume 7, 2005 Issue 3 > Paul E. Stamets . Antipox Properties of Fomitopsis officinalis (Vill.: Fr.) Bond. et Singer (Agarikon) from the Pacific Northwest of North America
Naranmandakh S, Murata T, Odonbayar B, et al. Lanostane triterpenoids from Fomitopsis officinalis and their trypanocidal activity. J Nat Med. 2018 Mar;72(2):523-529. doi: 10.1007/s11418-018-1182-1.
Han J, Li L, Zhong J, et al. Officimalonic acids A-H, lanostane triterpenes from the fruiting bodies of Fomes officinalis. Phytochemistry. 2016 Oct;130:193-200. doi: 10.1016/j.phytochem.2016.05.004.
Shi ZT, Bao HY, Feng S. Antitumor activity and structure-activity relationship of seven lanostane-type triterpenes from Fomitopsis pinicola and F. officinalis. Zhongguo Zhong Yao Za Zhi. 2017 Mar;42(5):915-922. doi: 10.19540/j.cnki.cjcmm.20170121.017.
Hu M, Zhang H, Feng B, Liu K, Guo S. Extraction of polysaccharides from Fomes officinalis Ames and their antitumor activity. Exp Ther Med. 2013;6(2):451–454. doi:10.3892/etm.2013.1163.
Wu HT, Lu FH, Su YC, et al. In vivo and in vitro anti-tumor effects of fungal extracts. Molecules. 2014 Feb 21;19(2):2546-56. doi: 10.3390/molecules19022546.
Hwang, C.H., B.U. Jaki, L.L. Klein, D.C. Lankin, J. McAlpine, J.G. Napolitano, S.G. Franzblau, S.H. Cho, P.E. Stamets, G.F. Pauli. 2012. "Biological and chemical evaluation of anti-TB coumarins from the polypore mushroom, Fomitopsis officinalis." Planta Medica 2012; 78 DOI: 10.1055/s-0032-1321157.
Teplyakova, T.V, N.V. Purtseva, T.A. Kosogova, V.A. Khanin, V.A. Vlassenko. 2012. Antiviral activity of polyporoid mushrooms (higher Basidiomycetes) from Altal mountains from Russia. International Journal of Medicinal Mushrooms. 14 (1):37-45.
S Sturm, K Gallmetzer, A Friedl, et al.Laricifomes officinalis – a rich source of pharmacologically active triterpenes. Planta Med 2016; 82(S 01): S1-S381DOI: 10.1055/s-0036-1596557.
UlrikeGrienke, et al. European medicinal polypores – A modern view on traditional uses. Journal of Ethnopharmacology, Volume 154, Issue 3, 3 July 2014, Pages 564-583.
Daria S. Khramova, Naranmandakh Shinen, Ganbaatar Jamsranjav, et al. Structure characterization of the mannofucogalactan isolated from fruit bodies of Quinine conk Fomitopsis officinalis. Carbohydrate Polymers, Volume 199, 1 November 2018, Pages 161-169.
Feng W, Yang JS. Structural Studies of Physiologically Active Polysaccharides of the Quinine Conk Fomitopsis Officinalis J Asian Nat Prod Res. 2015;17(11):1065-72. doi: 10.1080/10286020.2015.1054378.
Sha AL. Effects of the Fomes officinalis flavonoids on anti-senile action in the aging model mice. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2016 Feb 8;32(2):121-123. doi: 10.13459/j.cnki.cjap.2016.02.007.
Wuliya, Palida, BAI Li, et al. The immune-potentiating effect of fomes officinalis polysaccharides. Journal of Xinjiang Medical University, 2003-06.
Fijałkowska A, Muszyńska B, Sułkowska-Ziaja K, Kała K, Pawlik A, Stefaniuk D, Matuszewska A, Piska K, Pękala E, Kaczmarczyk P, Piętka J, Jaszek M. Medicinal potential of mycelium and fruiting bodies of an arboreal mushroom Fomitopsis officinalis in therapy of lifestyle diseases. Sci Rep. 2020 Nov 18;10(1):20081. doi: 10.1038/s41598-020-76899-1. PMID: 33208786; PMCID: PMC7674418.
Waill A Elkhateeb, Ghoson M Daba, Marwa O Elnahas, Paul W Thomas. Fomitopsis officinalis mushroom: ancient gold mine of functional components and biological activities for modern medicine. Egyptian Pharmaceutical Journal 18(4):285-289